NLRP3 and gout: For example, in a murine model of gouty arthritis, the compound was found to inhibit the IKK/NF-κB/TXNIP axis, leading to downregulation of NLRP3 and pro-IL-1β expression, ultimately attenuating inflammation and monocyte infiltration [27,57].